Showing results (231-240 of 283) with videos related to

Sort By:
Pageof 29
European Journal of Pharmacology|April 22, 1996
Affinities and intrinsic activities of dopamine receptor agonists for the hD21 and hD4.4 receptorsR A Lahti, A Mutin, E V Cochrane, et al.
The American Journal of Psychiatry|January 1, 1996
Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidolH H Holcomb, N G Cascella, G K Thaker, et al.
Psychiatry Research|September 8, 1995
Abnormal smooth pursuit eye movements in schizophrenic patients are associated with cerebral glucose metabolism in oculomotor regionsD E Ross, G K Thaker, H H Holcomb, et al.
Psychopharmacology|January 1, 1986
Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studiesC A Tamminga, R L Littman, L D Alphs, et al.
L'Encephale|January 1, 1982
Zinc and copper in patients with schizophreniaJ C Gillin, W T Carpenter, K M Hambidge, et al.
Artificial Organs|August 1, 1983
Schizophrenia and dialysisW T Carpenter, J H Sadler, P D Light, et al.
Archives of General Psychiatry|October 1, 1994
Neuropsychological impairments in deficit vs nondeficit forms of schizophreniaR W Buchanan, M E Strauss, B Kirkpatrick, et al.
Biological Psychiatry|July 11, 1992
Clinical predictors of relapse following neuroleptic withdrawalR W Buchanan, B Kirkpatrick, A Summerfelt, et al.
The American Journal of Psychiatry|May 1, 1997
Visual information-processing impairments in deficit and nondeficit schizophreniaJ R Bustillo, G Thaker, R W Buchanan, et al.
The American Journal of Psychiatry|April 14, 1999
Stability of the diagnosis of deficit syndrome in schizophreniaX F Amador, B Kirkpatrick, R W Buchanan, et al.
Pageof 29